AJNN
Academic Journal of Neurology and Neurosurgery

The Academic Journal of Neurology and Neurosurgery deals with Neurology and Neurosurgery accepts articles on these topics. Academic Journal of Neurology and Neurosurgery publishes original research articles, review articles, case reports, editorial commentaries, letters to the editor, educational articles, and conference/meeting announcements.

eISSN: 3023-6517
Creative Commons CC BY-NC-ND 4.0 International License.
EndNote Style

Online Manuscript System

Index
Review
General approach to headache diagnosis and treatment management
Abstract
Headache is common worldwide and is one of the leading causes of disability. Given its high prevalence and high burden in terms of disability, it is important for clinicians to have general knowledge about the approach to the patient presenting with headache. Headache disorders are classified according to their etiology. The most important step in the approach to headache is to investigate the presence of a secondary cause of pain with a detailed history and physical examination. The presence of symptoms and signs considered as red flags requires further investigation in terms of secondary causes. Treatment of pain is also directed towards the etiology. Treatment of secondary headache disorders is directed towards the cause of the pain. In primary causes, there are some pharmacologic and non-pharmacologic treatment approaches for the diagnosis.

Keywords : Headache, red flags, SNNOOP10

Download Article


1. Stovner LJ, Hagen K, Linde M, Steiner TJ. The globalprevalence of headache: an update, with analysis of theinfluences of methodological factors on prevalence estimates.J Headache Pain. 2022;23(1):34.
2. WHO, Världshälsoorganisationen. Atlas of headache disorders andresources in the world.Genève:Världshälsoorganisationen. 2011.
3. Stovner LJ, Nichols E, Steiner TJ, et al. Global, regional, and nationalburden of migraine and tension-type headache, 1990-2016: a systematicanalysis for the global burden of disease study. Lancet Neurol.2018;17(11):954-976.
4. Headache Classification Committee of the International HeadacheSociety (IHS). The international classification of headache disorders(beta version). Cephalalgia. 2013;33(9):629-808.
5. Mier RW, Dhadwal S. Primary headaches. Dental Clinics. 2018; 62 (4):611-628.
6. Ashina S, Mitsikostas DD, Lee MJ, et al. Tension-type headache. NatRev Dis Primers. 2021;7(1):24.
7. Friedman DI. Approach to the patient with headache. Continuum.2024; 30(2):296-324.
8. Doretti A, Shestaritc I, Ungaro D, et al. Headaches in the emergencydepartment-a survey of patients’ characteristics, facts and needs. JHeadache Pain. 2019;20:1-6.
9. Schankin CJ, Straube A. Secondary headaches: secondary or stillprimary. J Headache Pain. 2012;13:263-270.
10. Robbins MS. Diagnosis and management of headache: a review. Jama.2021;325(18):1874-1885.
11. Do TP, Cour Karottki NF, Ashina M. Updates in the diagnosticapproach of headache. Curr Pain Headache Rep. 2021;25(12):80.
12. Hansen P. More than a simple headache: using the SNNOOP10 criteriato screen for life-threatening headache presentations. J Urgent CareMed. 2023;17(9):18-21.
13. Garcia-Azorin D, Abelaira-Freire J, Gonzalez-Garcia N, et al.Sensitivity of the SNNOOP10 list in the high-risk secondary headachedetection. Cephalalgia. 2022;42(14):1521-1531.
14. Pohl H, Do TP, García-Azorín D, et al. Green Flags and headache: Aconcept study using the Delphi method. Headache. 2021;61(2):300-309.
15. Munoz-Ceron J, Marin-Careaga V, Peña L, Mutis J, Ortiz G. Headacheat the emergency room: Etiologies, diagnostic usefulness of the ICHD 3criteria, red and green flags. PLoS One. 2019;14(1):0208728.
16. Wijeratne T, Wijeratne C, Korajkic N, Bird S, Sales C, Riederer F.Secondary headaches-red and green flags and their significance fordiagnostics. NeurologicalSci. 2023;30:100473.
17. Ravishankar K. WHICH headache to investigate, WHEN, and HOW?Headache. 2016;56(10):1685-1697.
18. Kaniecki RG, Levin AD. Headache in the elderly. Handb Clin Neurol.2019;167:511-528.
19. Sharma TL. Common primary and secondary causes of headache in theelderly. Headache. 2018;58(3):479-484.
20. Bıçakçı Ş, Öztürk M, Üçler S, Karlı N, Siva A. Turkish neurologicalassociation headache study group practices. 2007;7(4)31-32.
21. Tfelt Hansen P, Pascual. Guidelines for controlled trials of drugs inmigraine: a guide for investigators. Cephalalgia. 2012;32(1):6-38.
22. Derry S, Rabbie R, Moore RA. Diclofenac with or without an antiemeticfor acute migraine headaches in adults. Cochrane Database Syst Rev.2013;(4): 8783.
23. Kelley NE, Tepper DE. Rescue therapy for acute migraine, part 1:tryptans, dihydroergotamine, and magnesium. Headache. 2012; 52 (1):114-128.
24. Boyer N, Signoret Genest J, Artola A, Dallel R, Monconduit L.Propranolol treatment prevents chronic central sensitization inducedby repeated dural stimulation. Pain. 2017;158(10):2025-2034.
25. Ayata C, Jin H, Kudo C, Dalkara T, Moskowitz MA. Suppression ofcortical spreading depression in migraine prophylaxis. Ann Neurol.2006;59(4):652-661.
26. Wu W, Ye Q, Wang W, et al. Amitriptyline modulates calcium currentsand intracellular calcium concentration in mouse trigeminal ganglionneurons. Neurosci Lett. 2012;506(2):307-311.
27. Ayajiki K, Okamura T, Toda N. Flunarizine, an anti-migraine agent,impairs nitroxidergic nerve function in cerebral arteries. Eur JPharmacol. 1997;329(1):49-53.
28. Do T, Hvedstrup J, Schytz H. Botulinum toxin: a review of the mode ofaction in migraine. Acta Neurol Scand. 2018;137(5):442-451.
29. Akın Takmaz S, İnan N, Üçler S, Akif M, İnan L, Başar H. Greateroccipital nerve block in migraine headache: preliminary results of 10patients. Agri. 2008;20(1):47-50.
30. Ashkenazi A, Matro R, Shaw JW, Abbas MA, Silberstein SD.Greater occipital nerve block using local anaesthetics alone or withtriamcinolone for transformed migraine: a randomized comparativestudy. J Neurol Neurosurg Psychiatry. 2008;79(4):415-417.
31. Zhao L, Liu J, Zhang F, et al. Effects of long-term acupuncture treatmenton resting-state brain activity in migraine patients: a randomizedcontrolled trial on active acupoints and inactive acupoints. PloS one.2014;9(6):99538.
32. Shah JP, Danoff JV, Desai MJ, et al. Biochemicals associated with painand inflammation are elevated in sites near to and remote from activemyofascial trigger points. Arch Phys Med Rehabil. 2008;89(1):16-23.
33. Ogunlaja OI, Goadsby PJ. Headache: treatment update. Eneurologicalsci.2022;29:100420.
34. Kaniecki RG. Tension-type headache. Biomed Pharmacother. 2015;1:149-160.
35. Harden RN, Rogers D, Fink K, Gracely RH. Controlled trial of ketorolacin tension-type headache. Neurology. 1998;50(2):507-509.
36. Martinez-Martin P, Raffaelli Jr E, Titus F, et al. Efficacy and safety ofmetamizol vs. acetylsalicylic acid in patients with moderate episodictension-type headache: a randomized, double-blind, placebo-andactive-controlled, multicentre study. Cephalalgia. 2001;21(5):604-610.
37. Silberstein SD, McCrory DC. Butalbital in the treatment of headache:history, pharmacology, and efficacy. Headache. 2001;41(10):953-967.
38. Packman E, Packman B, Thurston H, Tseng L. Lumiracoxib Is effectivein the treatment of episodic tension-type. Headache. 2005;45(9):1163-1170.
39. Pothmann R, Lobisch M. Acute treatment of episodic childhoodtension-type headache with flupirtine and paracetamol-a double-blindcrossover-study: gekreuzte doppelblindstudie. Der Schmerz. 2000;14:1-4.
40. Mørland T, Storli O, Mogstad TE. Doxepin in the prophylactictreatment of mixed ‘vascular’and tension headache. Headache. 1979;19(7):382-383.
41. Verhagen AP, Damen L, Berger MY, Passchier J, Koes BW. Behavioraltreatments of chronic tension-type headache in adults: are theybeneficial. CNS Neurosci Ther. 2009;15(2):183-205.
42. Kudrow L. Response of cluster headache attacks to oxygen inhalation.Headache. 1981;21(1):1-4.
43. Ekbom K, Monstad I, Prusinski A, et al. Subcutaneous sumatriptan inthe acute treatment of cluster headache: a dose comparison study ActaNeurol Scand. 1993;88(1):63-69.
44. May A, Leone M, Afra J, et al. EFNS guidelines on the treatment ofcluster headache and other trigeminal-autonomic cephalalgias. Eur JNeurol. 2006;13(10):1066-1077.
45. Ekbom K. Lithium for cluster headache: review of the literature andpreliminary results of long-term treatment. Headache. 1981;21(4):132-139.
46. Cohen AS, Matharu MS, Goadsby PJ. Trigeminal autonomiccephalalgias: current and future treatments: CME. Headache.2007;47(6):969-980.
Article available in :
Volume 1, Issue 3, 2024
Page : 56-63
https://doi.org/10.51271/AJNN-0014
Article Information
Received : 10 Tem 2024
Accepted : 31 Tem 2024
Published : 31 Tem 2024
Corresponding Author :

Zekiye Nur Haktanıyan: Department of Internal Medicine, Faculty of Medicine, Kırıkkale University, Kırıkkale, Turkiye

[email protected]
Citation : Varan E, Haktanıyan ZN. General approach to headache diagnosis and treatment management. Acad J Neurol Neurosurg. 2024;1(3):56-63.

Read: 143
Cited: 0
Download : 47
_Footer